Zaburzenia transportu receptorów GABA w epilepsji: od tworzenia do dysfunkcji synaptycznej
GABA Receptor Trafficking Disruption in Epilepsy: From Assembly to Synaptic Dysfunction
W skrócie
Epilepsja powstaje, gdy w mózgu jest zbyt dużo pobudliwości i zbyt mało hamowania. Receptory GABA są białkami, które hamują aktywność nerwów i chronią nas przed napadami padaczki. Gdy receptory GABA źle się transportują lub umiejscawiają w komórkach nerwowych (z powodu mutacji genów lub napadów padaczki), przestają działać prawidłowo, co prowadzi do napadów i powoduje, że leki przestają pomagać.
Oryginalny abstract (angielski)
Epilepsy is a complex neurological disorder characterized by recurrent seizures resulting from an imbalance between excitatory and inhibitory neurotransmission. γ-Aminobutyric acid type A receptors (GABARs), the principal mediators of fast inhibitory synaptic transmission, are essential for maintaining neuronal stability. Their function depends on tightly regulated trafficking processes, including subunit assembly in the endoplasmic reticulum, transport through the Golgi apparatus, membrane insertion, synaptic targeting, stabilization, and recycling. Disruptions in these processes, caused by genetic mutations, aberrant posttranslational modifications, or seizure-induced neuronal activity, impair receptor surface expression and localization, reducing inhibitory signaling and promoting network hyperexcitability. Evidence from human and animal studies indicates that altered GABAR trafficking contributes to epileptogenesis and pharmacoresistance, particularly during severe conditions such as status epilepticus. Understanding the molecular mechanisms regulating GABAR trafficking provides insights into epilepsy pathophysiology and highlights potential therapeutic strategies aimed at restoring inhibitory balance. By linking these trafficking mechanisms to synaptic structure and ion channel function, this review situates GABAR biogenesis within the broader framework of synaptic organization relevant to epilepsy and other neurological disorders.